Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities research analysts at William ...
Analysts have recently evaluated Charles River and provided 12-month price targets. The average target is $214.5, accompanied by a high estimate of $250.00 and a low estimate of $185.00. A 2.72% drop ...